News

Summary

This IDC MarketScape analyzes vendors of EHR systems to healthcare providers in Europe. It evaluates their current capabilities, future strategies, and comparative business in the marketplace. The evaluation is based on a comprehensive and rigorous framework that assesses vendors relative to the criteria and highlights the most influential factors for success in this market in the short and long terms. It serves as a valuable guide to help organizations make informed decisions in choosing the most suitable solution provider.

"With the aim to improve quality care, increase operational efficiency, and enhance clinicians' experience, European healthcare providers are actively seeking to harness the value of healthcare data by prioritizing investments in EHR systems," said Adriana Allocato, research manager, IDC Health Insights. "New EHR solutions include a wide breadth of functionalities for ensuring seamless data interoperability and integration as a foundation for data-driven care."

"Healthcare organizations understand that meeting current demand for healthcare services requires a strategy that not only prioritizes improved and equitable outcomes, but also empowers the workforce and enhances operational efficiency. Adopting reliable, secure, and scalable EHR solutions underpinned by an architecture that emphasizes technical, semantic, and process interoperability is crucial to meet these complex demands. They aim to unleash health data's potential, ensuring intelligent, seamless experiences and facilitating connections with broader healthcare ecosystems, paving the way for innovation and resilience," said Silvia Piai, research director, IDC Health Insights.

Summary

This IDC Health Insights study is a refresher of the life science R&D IDC MarketScape, which has a specific focus on strategic consulting in the life science R&D space. This document seeks to compare major service providers with each other based on criteria that should be important to life science companies when considering the selection of a strategic consulting partner to help provide guidance for strategic, operational, and tactical transformation issues within the R&D space. The IDC MarketScape assessment of strategic consulting outsourcing in life science R&D was previously performed in 2011, 2014, 2016, 2018, and 2021.

Dr. Nimita Limaye, research VP, Life Science R&D Strategy and Technology, IDC, notes, "Ongoing disruption, led by a pandemic, geopolitical turmoil, a recession, and the generative AI wave, have all resulted in a lot of uncertainty for the life sciences industry. As companies try to define the right strategy to forge ahead, they are trying to outline their digital transformation strategy, identify top priority use cases to guide their near-term and long-term IT investment road maps, and revamp their product portfolios while never losing focus on quality, risk, and compliance. The life sciences industry is leaning on its strategic consulting partners to lead the way and prepare their organizations to build digital resiliency and scale growth and innovation in a fast evolving, yet fluid world powered by 'AI everywhere.'"

Summary

This IDC Market Note examines the recent announcement that T-Mobile and its partners will be building the first 5G hybrid network in healthcare for Boston Children's Hospital. While private 4G/5G networks have been hot topics in the industry, their specific emphasis on connectivity within the four walls of the company facility presents limited utility for many organizations whose operations, customer interactions, and revenue-generating activity occur far from the company headquarters. Hybrid 5G networks that seamlessly integrate the security of onsite, zero trust connectivity with the mobility provided by leveraging the macro cellular network are not only critical for industries like healthcare that provide lifesaving services in a hospital setting but are also tasked with supporting clinicians and their patients in remote clinics and in at-home settings.

Summary

This IDC Market Presentation defines each of the four trends in payer IT to provide context for planning in 2024. It then provides essential guidance for payers within the context of these trends. These trends have been presented to multiple payer-supplying vendor user groups in 4Q23. Each trend is complex, nonintuitive, and layered.

"Payers are undergoing a crisis of relevance, cost, and increased consumer expectations. Their core business model is failing; they are limited by regulation, costs beyond their control, legacy technical debt, and a supercharged retail environment that causes their members to demand a retail-like excellence while providing the security and privacy of the past," says Jeff Rivkin, director of Payer IT Strategies at IDC Health Insights.

Summary

This IDC Survey reveals results from IDC's GenAI Awareness, Readiness, and Commitment (ARC) Survey. This survey investigates how healthcare leaders are assessing GenAI's potential impacts on their organizations in the next 18 months. It explores enterprise leaders' GenAI road map plans as well as the potential challenges and risks that GenAI poses for organizations.

"In this era of AI everywhere, healthcare is embracing the disruption and challenging the status quo, and banking on GenAI promises to drastically reduce the time and costs associated with a wide range of customer- and employee-facing use cases linked to automation and intelligence. This new era is changing our relationship with content as well as how we extract value and insights from structured and unstructured data," states Jennifer Eaton, research director, IDC Health Insights.

Summary

This IDC Market Presentation provides an IDC Industry Buyers Handbook, which aims to help technology vendors understand what drives buyers in the worldwide healthcare industry regarding their technology purchasing decisions. Vendors can use this handbook to:

• Identify the current trend-specific technology focus of buyer organizations
• Align the company's proposition with buyers' strategic priorities
• Position the technology offering to respond to buyers' business objectives
• Develop a compelling narrative that resonates with buyers' requirements

Technology vendors' executives in areas such as marketing, sales, and product strategy can leverage insights from this handbook to inform and formulate their approach with buyers within the worldwide healthcare industry. Insights provided in this handbook are largely based on IDC survey data and leverages senior IDC analysts' knowledge, IDC research, and ongoing conversations with key industry players.

"Amid economic and geopolitical uncertainties, global healthcare organizations must prioritize optimized IT infrastructure for current care delivery and innovation. As AI adoption surges, objective assessments of AI providers are essential. Collaboration with trusted automation experts is crucial for workforce enhancement and tackling labor shortages. The emphasis on patient engagement remains pivotal for improved health outcomes in this dynamic healthcare landscape," said Federico Mayr, research analyst, IDC Health Insights.

Summary

This IDC Perspective presents a summary of quotes from the HLTH conference held in Las Vegas, Nevada, October 8–11, 2023. At the HLTH conference, 150 sessions were held over 3 days showing the diversity and energy in the healthcare sector.

"The HLTH conference provides investors, vendors, providers, payers, and life science companies with a forum to enjoyably interact with snackable content, an energetic atmosphere, and a flash only found in Las Vegas. Healthcare and payer professionals should add this conference to their short list," states Jeff Rivkin, research director, IDC Health Insights.

Summary

This IDC Survey explores the key strategies and technology capabilities being prioritized by global medical device manufacturers to overcome major challenges, mitigate supply chain risks, and build long-term resilience.

The analysis presented here is based on a sample of medical device manufacturers that participated in IDC’s Global Supply Chain Survey, 2023, conducted in March among organizations from various industries across North America, Europe, and Asia/Pacific.

Summary

NVIDIA and Genentech have established a multiyear collaboration that leverages NVIDIA's generative AI capabilities and Genentech's data and machine learning (ML) capabilities to accelerate drug discovery. The feedback from each learning iteration will keep optimizing the model creating a learning "lab in a loop" model that will power innovation.

Summary

This IDC Survey examines results from IDC's Worldwide Future of Industry Ecosystems Survey.

In May and June 2023, we fielded our third annual global survey to 1,288 executives across 5 regions and 11 countries. The goal was to determine executive and business leader sentiment on industry ecosystems, maturity of current approach, and future plans for IT and use case investment. Respondents spanned multiple domains including CXOs, business-line executives, and IT leadership. Industry coverage is across 10 industries: architecture/engineering/construction (AEC); energy; discrete and process manufacturing (and subindustries); healthcare; life sciences; financial services; government and education; telco, media, and entertainment; retail; and transportation/logistics.

Key findings from the survey include:

• Improving end-customer engagement is a primary driver of industry ecosystems.
• AI is growing in importance as a key decision-support technology in industry ecosystems.
• Environmental sustainability remains a key initiative for industry ecosystem partners.

What is clear is that organizations in every industry are looking to open and expand their industry ecosystem as part of becoming a digital-first business. Shared data and insights, shared applications, and shared operations and expertise are enhanced with this approach — becoming not only a way to ensure flexibility and resiliency but also a way to grow revenue and profitability.

This document is focused on the healthcare industry. While operational efficiency and cost savings are paramount, improving patient engagement and of course outcomes through data, technology, and expertise continues to be a focus. To achieve this, healthcare organizations are focused on expanding their ecosystems to a multifaceted set of partners so there is on-demand and as-needed data, applications, capacity, and capability to complement their operations. Multiple examples of the future of industry ecosystems exist in this industry (highlighted in this document), proving the benefit of sharing data and insights, sharing and codeveloping applications, and sharing operations and expertise across ecosystems.

Summary

This IDC Perspective looks at key developments and news in the European healthcare market in 3Q23.

"In the third quarter of 2023, European healthcare organizations continued to grapple with persistent challenges, driving deals and investments in AI-driven solutions. Balancing innovation with the well-being of healthcare professionals continues to be paramount," said Federico Mayr, research analyst, IDC Health Insights Europe.

Summary

This IDC Perspective provides insights and recommendations for multinational healthcare organizations looking to accelerate their respective generative AI (GenAI) strategies based on discussion with Virtus Health's chief digital health officer, Jorge Silveira, on GenAI adoption in healthcare. With more than 40 fertility clinics, 63 laboratories, and seven hospitals worldwide, Virtus Health is one of the top five global providers of assisted reproductive services with presence in Australia, Singapore, Ireland, the United Kingdom, and Denmark. The company has piloted several GenAI-powered solutions across various parts of the business.

IDC believes in 2025, most enterprises will launch brands, products, and services that depend upon the tight integration of diverse AI services to reduce response times and staffing costs for meaningful outcomes to previously underserved customer segments.

"AI-driven solutions will advance beyond automation to deliver product design that understands and anticipates user needs, creating a more immersive and tailored user experience," says Linus Lai, VP of research and chief research analyst for Australia and New Zealand. "Enterprises that can tap into this trend, offering innovative solutions that seamlessly weave AI capabilities into everyday applications, will be at the forefront of this transformative wave in which companies no longer compete just on brand or price but on the intelligence and adaptability of their offerings."

Summary

This IDC study discusses how digital transformation accurately characterizes the life science industry's ongoing efforts to transform itself as it seeks to find new paths to innovation, optimize operational efficiency and effectiveness, and regain long-term sustainability. As in other industries, the digital transformation journey begins with a common definition of the mission, strategic priorities, and programs so that individual projects or use cases can better align with a life science company's overall goals and objectives.

"Digital transformation continues to transform patient and HCP engagement and fuel innovation in the life science industry. With the increasing adoption of newer technologies such as federated learning platforms, prescription digital therapeutics, and the metaverse, including AR, VR, and MR, it is essential to have a clear understanding of the digital taxonomy for life sciences and to be cognizant of the use cases where these disruptive technologies are being applied," says Dr. Nimita Limaye, research VP, Life Science R&D Strategy and Technology, IDC Health Insights.

"Digital transformation in the life science industry is moving forward rapidly. 3rd Platform technologies such as cloud, mobile, big data and analytics, and social data are already woven into the life science commercial arena. Emerging technologies like AI and RPA are accelerating productivity for commercial teams by maximizing message impact and relevance while reducing duplicate or confusing interactions with HCPs. In life science supply chains, IoT networks and platforms are enabling tracking and monitoring of sensitive and rare biologic drugs, allowing rapid deployment to patients in critical need around the globe. From the manufacturing floor to doctors' offices, digital technology is improving quality, efficiency, and patient experience," says Michael Townsend, research director, Commercial Life Sciences, IDC Health Insights.

Summary

This IDC Market Perspective discusses macroeconomic pressures and societal shifts that are creating new pharmaceutical and grocery supply chain deserts. Survey data from the life sciences industry indicates supply chain managers sense these shifts and are prioritizing investments to manage the supply chain response. Technology vendors will be called on to create solutions that optimize inventories, respond to consumer needs, and enable cost-efficient, direct-to-consumer models. This has the added benefit of serving a greater good for communities that would otherwise be left behind.

“In the past, pharmaceutical and grocery deserts would have been a large pain point for whole communities. With advancements in learning technologies, supply chain network optimization, and last-mile capabilities, the path is before businesses and technology vendors in these industries to provide vital services and products with creative and efficient solutions,” says Eric Thompson, research director, Worldwide Supply Chain Planning, IDC.

Summary

This IDC Market Presentation provides an IDC Industry Buyers Handbook that aims to help technology vendors understand what drives buyers within the European healthcare industry in their technology purchasing decisions. Vendors can use this handbook to:

• Identify the current trend-specific technology focus of buyer organizations
• Align the company's proposition with buyers' strategic priorities
• Position the technology offering to respond to buyers' business objectives
• Develop a compelling narrative that resonates with buyers' requirements

Technology vendors' executives in areas such as marketing, sales, and product strategy can leverage insights from this handbook to inform and formulate their approach with buyers within the European healthcare industry. Insights provided in this handbook are largely based on IDC survey data and leverages senior IDC analysts' knowledge, IDC research, and ongoing conversations with key industry players.

"In the current European healthcare landscape, making wise technology investments is crucial. Prioritizing shared record systems is essential for achieving a comprehensive patient view, which is integral to a more integrated approach to care. User-friendly patient solutions and AI-driven chatbots enhance patient engagement. Fostering a digital culture and embracing automation improve workforce efficiency and satisfaction. Lastly, nurturing a collaborative ecosystem and integrating diverse datasets empower healthcare organizations to proactively address inequalities," said Federico Mayr, research analyst, IDC Health Insights.

Summary

This IDC Tech Buyer Presentation explains how to leverage digital innovation in the healthcare industry. Patients, healthcare providers, and other industry stakeholders are now moving to a fully digitalized offline-to-online patient journey; this is opening new opportunities in the research and development of medicines and the delivery of healthcare services, while resolving barriers to treatment and improving patient outcomes. Healthcare organizations have digitally transformed to become a real digital business.

This presentation examines how running a digital business is more than integrating technology. As healthcare organizations' needs are firmly planted in a digital-first world, they need to constantly focus on innovation to address patient expectations, clinicians' experience, and the development of an ecosystem of multiple stakeholders.

This presentation was delivered on September 28, 2023, during IDC Directions Portugal, in Estoril. IDC Directions Portugal is one of the most important event about digital transformation in the country.

Summary

This IDC study provides IDC's top 10 predictions for future of industry ecosystems.

"The move to more open, extended, pan-industry ecosystems is the next phase of digital transformation. Organizations continue to recognize that innovation is more successful, resiliency is stronger, and customer, consumer, citizen, or patient experience is better with a varied, diverse ecosystem of partners in place," said Jeff Hojlo, research vice president, Future of Industry Ecosystems.

Summary

This IDC study provides executives across the globe with actionable insights and analysis for future healthcare industry scenarios.

"The 2024 worldwide healthcare industry predictions show that the industry is at an inflection point, being driven largely by the need to master AI everywhere and the drive to automate, while there continues to be a growing emphasis on sustainability and governance to build resilient systems that can adapt to evolving challenges," says Mutaz Shegewi, research director, IDC Health Insights. "The healthcare industry is not just navigating challenges but seizing opportunities for sustained growth. As the healthcare industry finds itself at the nexus of enduring, interconnected challenges and opportunities, traditional models are giving way to innovative paradigms demanding not just reactive measures but proactive strategic investments in technology and human capital. The imperatives for rapid action and strategic foresight have never been more pronounced as the industry landscape continues to evolve in complex, interlinked dimensions."

Summary

This IDC study discusses the top 10 predictions for the life sciences industry for 2024.

"'Reinvent' is very much the new tagline for the life sciences industry. The 2024 worldwide life sciences industry predictions focus on how the life sciences industry is reinventing itself by embedding 'as a service' and 'by design' strategies in its business models, leveraging GenAI to reimagine business processes, and weaving in intelligence and 'hyper-personalization' every step of the way," says Dr. Nimita Limaye, research VP, Life Sciences R&D Strategy and Technology at IDC Health Insights.

Summary

This IDC Market Presentation provides IDC's industry market forecast for healthcare providers (HCPs) in the Americas. It provides technology vendor product managers and those responsible for market/competitive intelligence with an industry overview of IDC spending guide forecasts numbers as well as insights into the regional healthcare market context influencing that spend for 2023.

This document includes:

• IDC's ICT market forecast for healthcare enterprises in the Americas
• IDC's market forecast for major IT applications for Americas healthcare enterprises
• Insights into key drivers and inhibitors that have impacted and will impact IT application investment sentiment in the Americas healthcare sector

The document also highlights recent initiatives by countries and organizations while providing top-level advice for technology suppliers for pursuing a business strategy that spans across the manufacturing value chain.

The document offers a foundation of industry knowledge to:

• Develop a compelling narrative that resonates with healthcare provider organizations
• Align product and service offerings with HCP organizations' priorities
• Show HCP organizations how technology implementation contributes toward the achievement of their goals
• Design short-, medium-, and long-term approaches to working with HCP organizations

Technology vendor executives in marketing, sales, product/service development, and market intelligence can leverage insight from this document as a starting point to organize their activities.

"The healthcare sector's shift toward digital-first strategies holds promise for enhancing patient engagement and healthcare delivery. Yet it amplifies cyberthreats and requires significant investments. To excel in this digital landscape, healthcare organizations must focus on patients and staff while implementing cybersecurity, data integrity, and ethical AI and promoting equitable access to technology-driven healthcare solutions," said Nigel Wallis, research vice president, Americas Industry Insights at IDC.

Summary

This IDC Market Note highlights the progress Oracle has exhibited in several core areas that are central to Oracle's future success. IDC also examines Oracle's recent FY 1Q24 earnings and looks for indications of progress around these key themes: cloud infrastructure, enterprise software, autonomous database, and industries, as well as the expansion and deepening of its partner ecosystem and further strengthening of the company's customer success focus and centricity.

Summary

This IDC Market Presentation provides a concise current state view of the Asia/Pacific healthcare sector, along with key insights into the impact of future trends and guidance for account strategies.

Tech sales leaders can use this information when seeking clarity about Asia/Pacific healthcare organizations' buying criteria and the impact of market trends. The presentation also offers insights based on customer data on IT spending patterns, competitive insights of the top vendors to the industry for specific application groups, market insights on current and future trends, and top market drivers and inhibitors, along with sourcing practices and plans.

IDC advises healthcare organizations on how to maximize the outcomes they desire from their technology programs and offers essential guidance to tech vendor sales leaders on strategies to capture growth opportunities in this market with targeted messages and offerings.

Summary

This IDC Market Presentation provides IDC's Industry Market Forecast for worldwide healthcare. It provides technology vendor product managers and those responsible for market/competitive intelligence with an industry overview of IDC spending guide forecasts numbers as well as insights into the regional healthcare market context influencing that spend for 2023.

This report includes:

• IDC's ICT market forecast for healthcare enterprises worldwide
• IDC's market forecast for IT applications for global healthcare enterprises
• Insights into key drivers and inhibitors that have impacted and will impact IT application investment sentiment in the worldwide healthcare industry

This document also highlights recent initiatives by countries and organizations while providing top-level advice for technology suppliers for pursuing a business strategy that considers the whole healthcare ecosystem.

"The healthcare sector's shift toward digital-first strategies holds promise for enhancing patient engagement and healthcare delivery. Yet it amplifies cyberthreats and requires significant investments. To excel in this digital landscape, healthcare organizations must focus on cybersecurity, data integrity, ethical AI, and equitable access to technology-driven healthcare solutions," said Federico Mayr, research analyst, IDC Health Insights.

Summary

This IDC Market Presentation provides technology vendors with an overview of key business trends shaping the Americas healthcare sector in 2023 and beyond. It offers a foundation of industry knowledge to help technology vendors develop a compelling narrative that resonates with healthcare provider clients, enables alignment of products and services with their organizational priorities, and demonstrates how relevant technology implementation contributes toward the achievement of their vision and goals.

"Healthcare organizations across the Americas are in the midst of a profound transformation. The COVID-19 pandemic has accelerated the pressing issues in the sector faced by workers and patients. As healthcare organizations concentrate on patient-centric care and on optimizing operational efficiency, it becomes crucial for technology vendors to comprehend prevailing market trends in healthcare," said Nigel Wallis, VP, IDC Insights.

Summary

In a pivotal move, Oracle demonstrated how it has seamlessly combined generative AI (GenAI) and voice-driven capabilities into its acquired Cerner electronic health record system at The Oracle Health Conference (OHC), which took place on September 18-21, 2023, as part of CloudWorld in Las Vegas, Nevada. The event also provided valuable insights into Oracle's healthcare industry plans, focusing on addressing complex challenges by improving system connectivity and addressing the need for an integrated approach to tackle these challenges, which marks an inflection point for the industry.

Summary

This IDC study evaluates the value-based health analytics market. The market is evolving as at-risk contracts tied to quality and cost performance mature and become more commonplace. Client needs are also evolving as a growing number of data types and sources such as SDOH become vital to support more robust analytics and AI/ML supported workflows. Whether supporting enhanced data analytics, risk stratification, interoperability, and/or end-user efficiency, the need for value-based healthcare analytics as the foundation for sustainability and success is becoming clearer.

"We have to meet clients where they are. This was the resounding call to action for value-based health analytic vendors represented in this IDC MarketScape. With a mixture of subject matter expertise, deep understanding of value-based payment models, innovative technology solutions, and advanced analytics and data science, many are well positioned to support their client's current and future value-based health goals." — Jennifer Eaton, research director, IDC Health Insights

Summary

This IDC Perspective serves as a guide to generative AI (GenAI) for healthcare providers and offers strategic insights into the technology, market-related trends, and actionable recommendations for technology buyers. GenAI is a transformative catalyst in reshaping healthcare paradigms, promising remarkable potential to revolutionize clinical and operational workflows. GenAI synergizes with healthcare professionals to amplify human capabilities, from streamlining clinical documentation to enhancing decision making. However, unleashing GenAI's full potential requires technological integration, ethical contemplation, and operational readiness. The intricate matrix of benefits and guardrails enveloping GenAI necessitates strategic navigation for responsible and impactful utilization.

"As healthcare providers navigate toward the future, the thoughtful embrace of GenAI emerges as a cornerstone for innovation, operational excellence, and heightened patient care," says Mutaz Shegewi, research director IDC Health Insights. "By blending GenAI with robust ethical considerations and ensuring human supervision at all times, healthcare stands poised to transform faster than ever."

Summary

This IDC Market Perspective highlights major announcements made at Google Cloud Next held in San Francisco on August 29–31, 2023, with a focus on how they will impact the following industries — education, financial services, government, healthcare and life science, and retail.

"AI is everywhere, and industry leaders are working tirelessly to adapt," said Matthew Leger, research manager, Government Insights at IDC. "Google's new AI capabilities, coupled with the company's robust partner ecosystem and industry solution approach, position Google — and by extension its customers — well to serve as a strategic partner to leaders across sectors."

Summary

This IDC Market Glance highlights the healthcare provider clinical IT solutions for 3Q23. "Healthcare providers gearing up for 2024 are bracing themselves for a multitude of intricate challenges that range from safeguarding against cyberthreats to tackling the intricacies of clinical data fragmentation," says Mutaz Shegewi, research director, IDC Health Insights. "Generative AI is being rapidly adopted and offers new opportunities for efficiency, especially in clinical documentation and patient engagement. Although inflationary pressures have not significantly impacted healthcare, providers must maintain meticulous yet competitive investment strategies and take advantage of advanced interoperability methods to become more data driven, as emphasized by the growing demand for adherence to HL7 FHIR standards. In this context, a balanced approach that combines sound financial strategy with technological agility will be essential to achieve more integrated, efficient, and patient-centric healthcare models."

Summary

This IDC Market Glance highlights the healthcare provider operational IT solutions for 3Q23. "The operational IT complexities faced by healthcare providers demand immediate action, as highlighted by recent IDC survey data. The future of healthcare is being shaped by pivotal elements such as GenAI, DevOps, and cybersecurity, which have gone beyond mere buzzwords and have become essential components. These technologies are fundamentally revolutionizing how healthcare operates, ranging from data management to infrastructure security," says Mutaz Shegewi, research director, IDC Health Insights. "It is imperative to adapt operational IT strategies to incorporate these disruptions to safeguard the organization's competitive edge and fortify its security posture within the complex healthcare environment."

Summary

This IDC Survey Spotlight analyzes deployment of a number of technologies in selected life science commercial applications and use cases, based on responses in IDC's May 2023 Life Sciences DX Survey.

Summary

This IDC PeerScape provides life science and healthcare executives with an understanding of the challenges faced in implementing generative AI to improve customer and clinician experience and accelerate drug discovery, provides examples of how these industries have tackled these challenges, and finally provides guidance for organizations to address these challenges.

"Generative AI is unexplored territory. Everyone wants to be a fast follower, yet very few will lead the way. But the opportunities it offers to the life science and healthcare industries are huge, and one cannot afford to play safe and turn a blind eye. From accelerating drug discovery to transforming the patient experience, generative AI will disrupt status quo across the value chain," says Dr. Nimita Limaye, research VP, Life Sciences R&D Strategy and Technology at IDC.

"Generative AI is rapidly evolving from a capability and potential use case perspective," said Jennifer Eaton, research director, Value-Based Health Digital Strategies at IDC. "Creating a well-vetted, strategic generative AI road map that considers short- and long-term value propositions and prioritizes key stakeholder transparency and building of trust will bolster the amount of value derived from scaled insights and AI investments."

Summary

This IDC Survey Spotlight analyzes digital transformation (DX) priorities in selected life science commercial applications and use cases, based on responses in IDC's May 2023 Life Sciences DX Survey.

Summary

This IDC Market Perspective summarizes key announcements during 3DS Industry Analyst Days 2023, held on May 31 and June 1, 2023, at the Dassault Systèmes headquarters in Paris. At the event, Dassault Systèmes executives presented the company's strategy, financial updates, and key industry-specific solutions with concrete customer examples.

"At Dassault Systèmes Industry Analyst Days, the company discussed the most important use cases and customer success stories for the multiple products it has and provided extensive demos across many industry-specific use cases. The company's strong focus and leadership will continue to be essential in executing its strategy and maintaining and growing its position in the market," said Erica Spinoni, IDC European Digital Business Practice and Future of Work.

Summary

This IDC Perspective discusses the growing importance of generative AI in powering drug discovery. It evaluates the significant potential of this opportunity, touches upon the challenges and complexities associated with the same, and highlights various generative AI approaches that have been implemented to discover new drugs. It maps the industry landscape, identifies key players involved, and provides guidance to the technology buyer on the implementation of this technology.

"The world of innovative TechBios and biotechs is exploding and will continue to grow exponentially. This will be followed by mergers and acquisitions. 'Design as a service' leveraging generative AI will serve to accelerate drug discovery and scale precision medicine strategy. These are still early days for the use of generative AI in drug discovery, and there will be hiccups and pushbacks. Navigating an evolving regulatory landscape and ensuring the trustworthiness of the models will be a daunting task. Yet the fire has been lit and generative AI will blaze a trail in the path for drug discovery. What was once mere science fiction is rapidly becoming a reality," said Dr. Nimita Limaye, research VP, Life Sciences R&D Strategy and Technology at IDC.

Summary

This IDC Presentation offers foundational insights into the Asia/Pacific healthcare sector in 2023 for sales, marketing, and product/channel managers in technology companies. By comprehending the sector’s structure, financing, and operations as well as its impact on individual and population health, managers can pinpoint areas within healthcare operations and subverticals in which their technology products and services can make a real difference.

This report delves into key healthcare parameters, funding and governance models, delivery systems, and driving forces behind the ICT spending of major healthcare provider (HCP) organizations in Asia/Pacific in 2023.

"Healthcare systems in Asia/Pacific are diverse, with varying levels of data and digital infrastructure maturity. Majority of the countries in the region have come out with strategic digital health initiatives. Sales and marketing leaders of tech providers should align their solutions and narratives with country-specific strategies and needs for increased acceptance and scalability," says Manoj Vallikkat, senior research manager, IDC Asia/Pacific Health Insights.

Summary

This IDC Market Presentation contains an industry analysis perspective that offers foundational insights into the global healthcare sector in 2023 for sales, marketing, and product/channel managers at technology companies. By comprehending the sector's structure, financing, and operations, as well as their impact on individual and population health, managers can pinpoint areas in healthcare operations and subverticals in which their technology products and services can make a real difference.

This report delves into key healthcare parameters, funding and governance models, and the driving forces behind ICT spending of major international private healthcare provider (HCP) organizations with a global footing in 2023.

"To excel in the global healthcare industry, tech vendors must grasp the unique health needs and dynamics of each region, customize solutions to each country, and forge local collaborations while continuing to innovate on a global scale," said Federico Mayr, research analyst, IDC Health Insights.

Summary

This IDC Survey Spotlight presents key findings from IDC's Worldwide Industry CloudPath Survey regarding key "trigger events" causing healthcare organizations to use cloud services.

"The reasons healthcare organizations are using cloud services has evolved from tactical like responding to IT budget constraints to more strategic initiatives such as digital transformation," stated Lynne A. Dunbrack, group vice president, Public Sector at IDC.

This IDC Survey Spotlight is based on IDC's April 2023 Worldwide Industry CloudPath Survey, which surveyed 100 U.S. providers' and 100 U.S. payers' cloud decision makers.

Summary

This IDC Survey Spotlight presents key findings from IDC's Worldwide Industry CloudPath Survey regarding industry clouds.

"Healthcare organizations have widely embraced industry clouds and will continue to do so," stated Lynne A. Dunbrack, group vice president, Public Sector at IDC, "because they accelerate speed to value with built-in integration, provide artificial intelligence tools to enable complex decision making, and help ensure regulatory compliance."

This IDC Survey Spotlight is based on IDC's April 2023 Worldwide Industry CloudPath Survey, which surveyed 100 U.S. providers and 100 U.S. payers cloud decision makers.

Summary

This IDC Perspective provides IDC Health Insights' overview of key IT deals, news, and digital initiatives in the worldwide medical devices market in 2Q23. This is the fourth in the new quarterly series of reports launched by IDC Health Insights following the expansion of its in-depth research coverage of the global medical devices industry.

"As medical device organizations worldwide navigate an increasingly complex healthcare landscape, the industry continues to focus on harnessing digital technologies to enhance efficiency and business performance, maximize value for customers, and align with the shifting healthcare paradigm toward patient-centricity and care personalization." — Research Manager Nino Giguashvili, IDC Health Insights

Summary

This IDC Survey analysis highlights the key trends in the life sciences (LS) from IDC's 2023 LS Digital Transformation Survey conducted in North America and Asia/Pacific to understand the current status of digital transformation initiatives in LS organizations today. This report focuses on the 41 LS organizations from Asia/Pacific out of 250 respondents.

The goal of the survey is to understand how digital transformation is impacting the LS value chain, key use cases with maximum ROI, industry building versus buying, and LS organizations' technology adoption maturity curve.

This presentation looks at investments in specific technologies to scale digital transformation, current challenges organizations are facing, and the current adoption rate of generative AI among LS organizations.

"LS in Asia/Pacific is moving toward innovation, with over three quarters of the respondents undergoing digital transformation. Although they prioritize decentralized clinical trials and faster drug design, generative AI has opened a new phase of accelerated innovation that organizations will leverage for new capabilities, including developing precision drugs, augmenting workflow efficiency, and enhancing patient experience. Moving forward, there will be an increased focus on cybersecurity measures and key performance indicator (KPI)–based partnership ecosystems to keep the digital transformation system strong and running," says Manoj Vallikkat, senior research manager, IDC Asia/Pacific Health Insights.

Summary

This IDC Health Insights study has a specific focus on real-world evidence, real-world data, platforms, technologies, and consulting services in the life science industry. This document is a qualitative and quantitative assessment based on criteria that should be important to life science companies when considering the selection of an RWD/RWE technology solution provider. This is the first time that an IDC MarketScape assessment on this topic in life sciences has been performed.

"The pharma industry is aggressively building modernized data estates of complex diverse data sets, leveraging technologies for the ingestion, integration, transformation, and tokenization of the same, to cull out extremely valuable insights that will shorten development timelines, scale the probability of technical and regulatory success, and improve clinical outcomes. Data is indeed the new gold, and data magnates are ruling this industry," said Dr. Nimita Limaye, research VP, Life Science R&D Strategy and Technology, IDC.

Summary

This IDC Market Glance highlights healthcare provider operational IT solutions in Europe for 3Q23.

"As healthcare organizations strive for more digitalization, they face obstacles in transitioning to new care models based on personalization and integration of services along the patient journey," said Adriana Allocato, research manager, at IDC Health Insights Europe. "Workforce shortages, inflation, supply chain constraints, reduced budgets, and depleted resources are pushing healthcare organizations to increase their investments in workflow and operational effectiveness solutions to eventually accommodate new processes and address the more competitive requirements of an increasingly private healthcare market."

Summary

This IDC Market Presentation examines the IDC Digital Transformation Use Case Taxonomy research documents in select industries including value-based health, experiential retail, insurance, telecommunications, and technology-oriented value chains in manufacturing. We highlight the newest digital transformation use cases in these industry-focused taxonomy documents, many of which are bridging the gap to the digital business era at many organizations. Finally, we identify repeated trends across industries, such as intelligence and AI, and offer recommendations for technology suppliers based on this research.

Summary

This IDC Tech Buyer Presentation identifies the digital transformation (DX) use cases associated with life science strategies and provides guidance on how to prioritize them to develop a DX road map.

Summary

This IDC Survey Spotlight looks at the most strategic generative AI technology partners for the life science and healthcare industries. While the number of technology providers in the generative AI (GenAI) space is exploding, the life science industry has a very clear vision of partnering with public cloud providers, followed by digital infrastructure partners and IT consulting partners. Healthcare has also given some preference to GenAI tool providers and to the start-up ecosystem. In detail:

• The top barriers for the use of GenAI for the life science industry include data security, the trustworthiness of GenAI, and access to quality data. Access to large, domain-specific data sets to train and fine-tune large language models (LLMs) remains an ongoing challenge for the life science industry. Data security also tops the list for the healthcare industry, followed by data privacy, which is not surprising considering that both industries are dealing with highly sensitive patient data.
• What is striking, however, is the fact that the third barrier for the healthcare industry is a simple belief that GenAI is not required. In contrast, this comes last in the list of barriers for the life science industry.
• Life sciences foresees customer engagement, supply chain, and product and software development/design as business areas where GenAI will have the maximum impact in the next 18 months. Customer engagement and product design also ranked highest in the list for healthcare. One sees growing interest in developing intelligent patient summaries to drive personalized conversations with patients, improving the patient experience and outcomes.
• The three GenAI use cases having the maximum promise for both life sciences and healthcare were knowledge management applications, design applications, and code generation applications.
• While close to 30% of the life science industry was investing significantly in GenAI in 2023, only 10% of the healthcare industry was doing so; more than half of both the industries were exploring potential use cases.

Summary

This IDC Survey Spotlight derives data from IDC's 2023 Future Enterprise Resiliency and Spending Survey (FERS), Wave 6, with a focus on healthcare organization's generative AI adoption trends and potential barriers.

"While generative AI remains a hot topic, garnering lively debate on most promising healthcare use cases, the challenges of developing private large language models and the overall data privacy and security concerns, and implementation timelines are proving harder to pin down, which means more emphasis being placed on rollout plans for 2024 and beyond," says Jennifer Eaton, research director, IDC Health Insights.

Summary

This IDC Tech Buyer Presentation provides a road map over three time horizons to prioritize deployment of each of the digital transformation use cases found in IDC's Worldwide Digital Transformation Use Case Taxonomy, 2023: Value-Based Health (IDC #US51044123, August 2023). Every organization should evaluate its own digital transformation strategy against the road map and make adjustments as needed based on regional and organizational circumstances.

"As healthcare organizations continue to modernize infrastructures to support cost-effective, high-quality, and equitable care, investments in AI, machine learning, and emerging generative AI tools are driving the goals of efficiency and automation while necessitating the need for careful use case vetting and strategic road map creation to ensure success." — Lynne Dunbrack, group vice president, IDC Health Insights

Summary

This IDC Market Presentation provides insights into the top 10 fastest-growing European agile work use cases from the IDC Worldwide Digital Transformation Spending Guide — April 2023 (V1 2023). For each use case, this report guides vendors in moving technical conversations with traditional IT contacts to use-case-based conversations with workforce executives (e.g., chief human resource officers, chief talent officers, chief learning officers) and broader line-of-business (LOB) and IT audiences, serving as a reference for sales pitches. The report:

• Highlights workforce personas involved in steering, financing, and influencing use cases and how they should collaborate to ensure the successful implementation of the use case
• Understands workforce-specific and overarching technology as well as architecture requirements
• Provides detailed examples of end users working and implementing each workforce/workplace/workspace-related use case

"European CEOs are still eager to invest in digital and technology solutions to enable a hybrid workplace as well as to attract and retain talents and skills, showing how workforce-related technologies still have high growth potential. On average, the use cases in the agile work lane grow faster than broader digital spending, a market still growing at a double-digit growth rate," said Erica Spinoni, senior research analyst, European Digital Business Practice and Future of Work.

Summary

This IDC Innovators profiles three emerging vendors: Current Health, Huma and TytoCare. These companies offer to the global healthcare and life sciences ecosystem innovative digital health solutions for remote patient engagement and virtual care to enable patient-centric healthcare delivery models and decentralized clinical trials. IDC Innovators are emerging vendors with revenues more than $100 million that have demonstrated either a groundbreaking business model or an innovative new technology — or both.

"Technology-enabled virtual care solutions have become pivotal at the intersection of healthcare and life sciences to support remote patient monitoring and engagement, driving a transformative shift toward new, patient-centric models of health care delivery and clinical research," said Nino Giguashvili, research manager, IDC Health Insights. "Following the period of exponential surge experienced throughout the COVID-19 pandemic, virtual care has now reached a critical juncture that will shape its future trajectory. The vendors featured in this report exemplify the evolution of business models and value propositions, as they work toward seamlessly integrating, standardizing, and scaling the scope of virtual care within the broader patient journey," said Silvia Piai, research director, IDC Health Insights.

Summary

This IDC Market Note provides a summary of the AHIP 2023 conference held in Portland, Oregon.

"It is impossible to divorce data, trust, AI, and equity," says Jeff Rivkin, research director, Payer IT Strategies at IDC Health Insights. "Perhaps that is why the AHIP 2023 panels focused on equity and trust, and then conversations inevitably evolved to data and AI. The AHIP conference has changed its name and faces over the past few years, but the core challenge of payers is still navigating the interconnectedness of it all."

Summary

This IDC study discusses how healthcare organizations are on a mission to digitally transform to create a value-based healthcare system, even though they may not use the term digital transformation as extensively as other industries such as retail or financial services do. While the pandemic drove unprecedented adoption of virtual visits and other forms of remote care, the number of use cases powered by a range of artificial intelligence technologies, especially with emerging generative AI capabilities, will continue to grow in 2023 and beyond.

"Building on their investments in cloud, intelligence data management, and connected health technologies to enable care anywhere, healthcare organizations are increasing their investments in AI, machine learning, and emerging generative AI tools to streamline clinical workflows and further refine their plans for reimagining the delivery of care," says Lynne A. Dunbrack, group vice president, IDC Health Insights.

Summary

This IDC Survey Spotlight looks at the appetite for augmented reality as a service (ARaaS) in the United States. We polled 349 IT decision makers on their interest in ARaaS, and because we also asked them which vertical markets they represented, we were able to look at ARaaS demand by industry (industry defined as a group of similar vertical markets).

"As the market for augmented reality (AR) devices ramps up, so too will the need for ARaaS," says Ramon T. Llamas, research director with IDC's Augmented and Virtual Reality team. "ARaaS draws its roots to device as a service (DaaS) to demonstrate cost savings, IT workload reduction, and streamlined device replacement. Many of the same approaches and benefits can be applied to AR.

"At the same time, different industries are moving at different trajectories, and vendors should be wary of that," adds Llamas. "Manufacturing has long been active in the AR space with multiple use cases and proven value generation, making it the perfect spot to launch ARaaS. Others like wholesale/retail trade/transportation and warehousing may have more specific segments and needs for vendors to focus on. Regardless of which industry and vertical and because this is an emerging market, vendors and companies need to be flexible in their ARaaS approaches."

Summary

This IDC Market Presentation contains an industry analysis perspective that offers foundational insights into the European healthcare sector in 2023 for sales, marketing, and product/channel managers at technology companies. By comprehending the sector's structure, financing, and operations as well as its impact on individual and population health, managers can pinpoint areas in healthcare operations and subverticals in which their technology products and services can make a real difference.

This report delves into key healthcare parameters, funding and governance models, delivery systems, and the driving forces behind ICT spending of major healthcare provider (HCP) organizations in Europe in 2023.

"Tech vendors in the European healthcare sector should tailor sales and marketing strategies to meet the unique needs of each country's healthcare system. Collaboration with local players and a focus on improving patient health outcomes will lead to success," Federico Mayr, research analyst, IDC Health Insights.

Summary

This IDC Market Presentation aims to provide technology vendor product managers and those responsible for market/competitive intelligence with an industry overview of IDC spending guide forecast numbers and insights into the regional healthcare market context influencing that for 2023.

This report includes:

• The IDC ICT market forecast for healthcare enterprises in Asia/Pacific
• The IDC market forecast for IT applications for Asia/Pacific healthcare enterprises
• Insights into key drivers and inhibitors that impacted and will impact IT application investment sentiment in the Asia/Pacific healthcare sector

The document also highlights recent initiatives by countries and organizations while providing top-level advice for technology suppliers in pursuing a business strategy that spans across the healthcare value chain.

"The IT investments in the healthcare sector are seeing increased growth across enterprise applications, mainly to strengthen the healthtech ecosystem and increase operational productivity to ensure a seamless care shift from hospitals to patients. It is vital for tech suppliers to support healthcare enterprises to see the future promise and consumer/patient demands to ensure outcome-based IT spend," says Manoj Vallikkat, senior research manager, IDC Asia/Pacific Health Insights.